| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3041 |
| Trial ID | NCT05391490 |
| Disease | Hematologic Cancer |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | KCAT19 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies |
| Year | 2022 |
| Country | United Kingdom |
| Company sponsor | University College, London |
| Other ID(s) | UCL/126900|2021-002878-88 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||